Overall rank by patents
#42,170
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, active 2015–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
Osio holds 6 US patents across 6 technology areas, rank #42,170 of 50,000 tracked assignees.
Osio Corporation has been granted 6 US utility patents between 2015 and 2021, placing Osio Corporation at rank #42,170 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.5 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Osio Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Osio sits between Ortho Organizers, Inc. (6 patents, rank #42,166) and Osteal Therapeutics, Inc. (6 patents, rank #42,174) - the closest US assignees by grant volume. The composite Innovation Score of 27.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 5 in the 2015–2019 window, a -80% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Osio Corporation's 19.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Osio Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Ortho Organizers, Inc.
6 patents
Ortho-Space Ltd.
6 patents
Orthocell Limited
6 patents
Orthopaedic International, Inc.
6 patents
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság
6 patents
Ossvis Co., Ltd.
6 patents
Ostara Biomedical Ltd.
6 patents
Osteal Therapeutics, Inc.
6 patents
Osio Corporation
6 patents
What this shows Osio holds 6 patents at rank #42,170, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #42,170 in granted patent volume.
Other assignees with the most granted patents in Osio's primary technology class.
Osio's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
27 Top 78% higher than 22% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 16.7% |
| 2016 | 1 | 16.7% |
| 2017 | 1 | 16.7% |
| 2018 | 1 | 16.7% |
| 2019 | 1 | 16.7% |
| 2021 | 1 | 16.7% |
Top 6 of 6 technology areas
Overall rank by patents
#42,170
Across all tracked assignees
27.1 out of 100
How to use this portfolio
Osio's 6 grants land it in the top 78% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.